Chen Kan

Years Active: 2022-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenya Tan, Ke Pan, Minqiong Sun, Xianzhu Pan, Zhi Yang, Zhiling Chang, Xue Yang, Jicheng Zhu, Li Zhan, Yakun Liu, Xiaofei Li, Keqiong Lin, Lin Chen, Hui Mo, Wei Luo, Chen Kan, Lunxi Duan, Hong Zheng
CCKBR+ cancer cells contribute to the intratumor heterogeneity of gastric cancer and confer sensitivity to FOXO inhibition. Cell death and differentiation (2024)
Chen Kan, Jiazhao Yang, Haitao Fan, Yuanjuan Dai, Xingxing Wang, Rui Chen, Jia Liu, Xiangyue Meng, Wei Wang, Guiling Li, Jiao Zhou, Ya Zhang, Wanbo Zhu, Shiyuan Fang, Haiming Wei, Hong Zheng, Siying Wang, Fang Ni
Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss. Bone research 10 (1) (2022)
Chen Kan, Jiazhao Yang, Haitao Fan, Yuanjuan Dai, Xingxing Wang, Rui Chen, Jia Liu, Xiangyue Meng, Wei Wang, Guiling Li, Jiao Zhou, Ya Zhang, Wanbo Zhu, Shiyuan Fang, Haiming Wei, Hong Zheng, Siying Wang, Fang Ni
Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss. Bone research 10 (1) (2022)

Chen Kan.css-eqlu8i{font-size:small;padding-left:4px;}